APA

Kallel Sellami M., Zitouni M., Tombari W., Ben Ayed M., Abida O., Laadhar L., Mokni M., Fezza B., Turki H., Mokhtar I., Ben Osman A., Kamoun Mohamed R., Joly P., Tron F., Gilbert D., Masmoudi H. & Makni S. (20070626). Anti-desmoglein-1 antibodies are prevalent in Tunisian patients with hydatidosis and leishmaniasis. : The British journal of dermatology.

Chicago

Kallel Sellami M, Zitouni M, Tombari W, Ben Ayed M, Abida O, Laadhar L, Mokni M, Fezza B, Turki H, Mokhtar I, Ben Osman A, Kamoun Mohamed R, Joly P, Tron F, Gilbert D, Masmoudi H and Makni S. 20070626. Anti-desmoglein-1 antibodies are prevalent in Tunisian patients with hydatidosis and leishmaniasis. : The British journal of dermatology.

Harvard

Kallel Sellami M., Zitouni M., Tombari W., Ben Ayed M., Abida O., Laadhar L., Mokni M., Fezza B., Turki H., Mokhtar I., Ben Osman A., Kamoun Mohamed R., Joly P., Tron F., Gilbert D., Masmoudi H. and Makni S. (20070626). Anti-desmoglein-1 antibodies are prevalent in Tunisian patients with hydatidosis and leishmaniasis. : The British journal of dermatology.

MLA

Kallel Sellami M, Zitouni M, Tombari W, Ben Ayed M, Abida O, Laadhar L, Mokni M, Fezza B, Turki H, Mokhtar I, Ben Osman A, Kamoun Mohamed R, Joly P, Tron F, Gilbert D, Masmoudi H and Makni S. Anti-desmoglein-1 antibodies are prevalent in Tunisian patients with hydatidosis and leishmaniasis. : The British journal of dermatology. 20070626.